The government will also evacuate Indians on Friday from China's Wuhan city, the epicentre of the deadly Coronavirus, which has spread to at least 17 countries already.
A person from Kerala with a travel history to China has been tested positive. Health ministry said the patient is stable and is being closely monitored.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
'There is no data to show this virus is more deadlier.'
The death of a 11-year-old boy due to 'bird-flu', even before the devastating effects of the second Covid wave have waned, has alarmed the medical fraternity though they assert that human-to-human transmission of H5N1 virus is extremely rare. The event has also put the Rs 90,000 crore domestic poultry industry which was seeing some uptick in demand after months of low sales last year into a spot of bother, as any curb on sale or production of eggs or chicken could have a devastating impact on its revenues. It is estimated that around 60 million people are directly impacted by the poultry sector in India. H5N1 virus, also commonly known as bird flu, is known to spread from chickens but other birds such as ducks and crow are also carriers of the virus.
A control room has also been set up and the Strategic Health Operations Centre (SHOC) of the National Centre for Disease Control (NCDC) has been activated, phone number for which is 011-23978046, a health ministry statement stated.
It will be unfair to put a date for any COVID wave as the behaviour of coronavirus is unpredictable and a disciplined and effective pandemic response can help the country get away from any significant outbreak, COVID Task Force chief V K Paul said.
Samples of these seven passengers have been sent to the ICMR-NIV Pune lab. Samples of four other passengers tested earlier have been confirmed to be negative for nCoV by the lab.
As Kerala reeled under a daily increase of nearly 30,000 cases of COVID-19, the deadly Nipah virus has come as another thorn in its side, prompting the state to further heighten the alertness of its health machinery to prevent an outbreak of a different infection.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
A coronavirus positive woman allegedly managed to give the slip to authorities in New Delhi after her arrival from London and reached Andhra Pradesh by train only to be picked up by authorities and admitted to a hospital.
It took 64 days for COVID-19 cases in India to touch the (May 19) one lakh-mark from 100 cases, and another fortnight to cross two lakh cases on June 3. It took 10 days for the tally to touch the three lakh-mark and another eight days for the cases to climb to four lakh.
The Centre is conducting a study to assess the presence of SARS-CoV-2, or novel coronavirus, in the Ganga as corpses were found dumped in the river during the second Covid wave, and were fished out from districts in Uttar Pradesh and Bihar, officials said.
The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.
According to the latest data available from the Centre and the states in the night, the total number of Omicron cases in the country was around 1,200.
"Why did Modi ji's government send more vaccines abroad, while vaccinating less people in India?"
A joint venture of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises (ASE), and CoDiagnostics, CoSara Diagnostics is the first and only Indian company so far to receive a licence from the Central Drugs Standard Control Organisation (CDSCO) to manufacture coronavirus diagnostic test kits.
According to SOP, those testing positive will be isolated in a separate unit of an institutional facility.
Trump indicated that his administration is looking at a bigger compensation from Beijing than the $140 billion being sought by Germany over the coronavirus pandemic.
Most of those who tested positive either recently arrived from African countries or were in contact with such people.
With number of swine flu cases crossing 27,880, government on Tuesday said the virus would continue to circulate though no mutation was taking place.
Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.
All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
Rio Olympian and Indian long distance runner Sudha Singh, who was undergoing treatment at a private hospital here for a suspected Zika virus infection, has tested positive for swine flu and will be out of action for at least two months, doctors said on Tuesday. "Sudha Singh who has been undergoing treatment for a suspected Zika virus is suffering from H1N1, known as swine flu virus," Dr Sarala of Sports Authority of India told PTI in Bengaluru.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
However, experts in the fields of genome sequencing and cell science have observed that such a small sample size cannot be considered as an indication of the spread of the mutated virus.
According to the World Health Organisation, 10 candidate vaccines for COVID-19 are in the clinical evaluation and 126 are in the pre-clinical stage.
Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.
'We need to prove to the world that quality vaccines and R&D are possible in India.'
Health Minister Harsh Vardhan advised people to refrain from non-essential travel to Iran, Italy, South Korea and Singapore.
The first nationwide mock drill was held on January 2 which, the health ministry said, helped to iron out any glitches in the final execution and further refinement of the operational procedures.
The Centre on Wednesday deployed multi-disciplinary teams in bird flu-affected areas of Kerala and Haryana, while Madhya Pradesh, where crows have died due to the influenza, banned the entry of chicken consignments from southern states for 10 days as a precautionary measure.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
'A decision on the IPL matches against the backdrop of coronavirus to be held in Mumbai will be taken at the state cabinet meeting on Wednesday.'
No Ebola case detected in the country so far; experts say a robust preparedness plan to fight the virus missing.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
'The media hype that the Gir lion species is in danger is totally wrong.'
Three more positive cases of novel coronavirus have been reported in India.
The United States intelligence community has failed to reach any firm conclusion on the exact origin of COVID-19 and is split on whether it leaked from a lab in China or emerged in nature, even though it does not believe the virus was developed as a biological weapon, according to results of a detailed review ordered by President Joe Biden.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances